Migdal Insurance & Financial Holdings Ltd. Kamada LTD Transaction History

Migdal Insurance & Financial Holdings Ltd.

$6.18 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 31, 2022	SELL	$4.42 - $5.43 $530,400 - $651,600	-120,000 Reduced 25.99%	341,674 $1.54 Million
Q4 2017 Feb 06, 2018	SELL	$4.35 - $5.15 $500 - $592	-115 Reduced 0.02%	461,674 $2.19 Million
Q3 2017 Nov 06, 2017	SELL	$4.25 - $4.8 $6,991 - $7,896	-1,645 Reduced 0.35%	461,789 $2.22 Million
Q2 2017 Aug 15, 2017	BUY	N/A	463,434	463,434 $2.78 Million

Others Institutions Holding KMDA

# of Institutions

Shares Held

6.48M

Call Options Held

200

Put Options Held

Phoenix Holdings Ltd. Givatayim, L3

1.83M
Shares

$10.8 Million
0.15% of portfolio
Vanguard Group Inc Valley Forge, PA

1.38M
Shares

$8.17 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

856K
Shares

$5.05 Million
0.01% of portfolio
Y.D. More Investments LTD Ramat Gan, L3

710K
Shares

$4.19 Million
0.4% of portfolio
Wells Fargo & Company San Francisco, CA

630K
Shares

$3.72 Million
0.0% of portfolio

View Full List

About KAMADA LTD

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $264M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

More about KMDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Migdal Insurance & Financial Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Migdal Insurance & Financial Holdings Ltd. with notifications on news.

Account